FINNENCE ▪ THE WIRE FILE
THE WIRE · № 84243
News■ Unclear/unknown
Devonian Health Group Provides Update on its Planned NYSE American Listing
KINDNews
DIRECTION■ Unclear/unknown
SOURCES1
ENTITIES1
STORY SIZESTANDALONE
FIRST SEEN
LAST UPDATE
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
A TSXV/OTC company updating a planned NYSE American listing is a microcap capital-markets event with negligible index impact.
Microcap listing process, immaterial to markets
CATALYST TO WATCH
Actual NYSE American listing completion
MAIN RISK
Offering may not price or complete
FULL DISPATCH
QUEBEC CITY, Oct. 16, 2026 /PRNewswire/ -- Devonian Health Group Inc. ("Devonian" or the "Company") (TSXV: GSD) (OTCQB: DVHGF) today provides an update on its proposed listing on the NYSE American in connection with its initial public offering in the United States (the "Offering"), as...
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
AFFECTEDHealthcare
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
→CORRELATIONshares Healthcare
Alnylam founder's new biotech lands $200M in upsized IPO2026-10-16 14:18 UTC
Alnylam founder's new biotech lands $200M in upsized IPO2026-10-16 14:18 UTC
→CORRELATIONshares Healthcare
City’s IPO soars to $200M, with proceeds supporting thromboembolic disease pipeline2026-10-16 13:45 UTC
City’s IPO soars to $200M, with proceeds supporting thromboembolic disease pipeline2026-10-16 13:45 UTC
→CORRELATIONshares Healthcare
Buyers reward strong fundamentals as M&A accelerates2026-10-16 14:27 UTC
Buyers reward strong fundamentals as M&A accelerates2026-10-16 14:27 UTC
→CORRELATIONshares Healthcare
Sickle cell gene therapies offer new hope, but access remains a major challenge2026-10-16 14:43 UTC
Sickle cell gene therapies offer new hope, but access remains a major challenge2026-10-16 14:43 UTC
→CORRELATIONshares Healthcare
City Therapeutics allocated no shares to half of IPO orders2026-10-16 14:48 UTC
City Therapeutics allocated no shares to half of IPO orders2026-10-16 14:48 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.